Mutations of the TSC1 and TSC2 genes can affect the mechanistic target of the rapamycin (mTOR) signaling pathway and thus disrupt the regulating mechanisms of cell growth and proliferation, leading to tumor development [20]. The gene discussed is TSC1; the disease is neoplasm.